IPN News

News
all
press releases
Investing.com - European pharmaceutical stocks offer solid growth, valuations near 10-year lows, and a possible safe haven from challenges related to U.S. President Donald Trump's tariff plans, according to analysts at Morgan Stanley (NYSE:MS).
investing.com

Advertisement|Remove ads.